GlassScriptPhysician profile
Nickos Hatzis
NPI 1598723298
$11,324.51
in general payments reported to CMS, 2019-2025
23 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,370 · 2020: $309 · 2021: $458 · 2022: $1,192 · 2023: $143 · 2024: $125 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $8,065.10 | 2019-2024 | Inhance |
| Arthrex, INC. | $593.68 | 2022 | |
| Alon Medical Technology | $434.10 | 2022 | |
| Pacira Therapeutics, INC. | $299.88 | 2019-2021 | |
| Baxter Healthcare | $268.81 | 2025 | Tisseel, Floseal |
| Horizon Therapeutics Plc | $234.28 | 2019-2022 | |
| Stryker Corporation | $201.99 | 2019-2025 | Mako, Tornier Perform Reversed Augmented Glenoid, Pangea |
| Siemens Medical Solutions USA, INC. | $170.36 | 2025 | Magnetom Altea, Magnetom Sola |
| Depuy Synthes Sales INC. | $158.96 | 2019-2021 | |
| Boston Scientific Corporation | $134.65 | 2021-2023 | |
| Fx Shoulder Solutions, INC | $122.20 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $92.41 | 2020-2025 | Exparel, Iovera, Zilretta |
| Sanofi-Aventis U.S. LLC | $92.08 | 2019-2023 | |
| Bioventus LLC | $89.80 | 2021-2025 | Durolane, Gelsyn-3 |
| Ethicon US, LLC | $64.53 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $61.22 | 2024-2025 | Irrisept |
| Medtronic USA, INC. | $59.12 | 2019 | |
| Ferring Pharmaceuticals INC. | $58.23 | 2020-2023 | Euflexxa |
| Smith+Nephew, INC. | $38.15 | 2019-2020 | |
| Ermi LLC | $25.25 | 2021 | |
| Convatec INC. | $24.25 | 2022 | |
| Davol INC. | $18.27 | 2024 | Arista Ah Flexitip |
| Lundbeck LLC | $17.19 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nickos Hatzis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.